Status:

COMPLETED

Clofazamine for the Treatment of Mycobacterium Avium Intracellulare(MAI)

Lead Sponsor:

Yale University

Conditions:

Infection, Mycobacterium Avium-Intracellulare

Eligibility:

FEMALE

Brief Summary

This protocol is an single patient IND to provide clofazamine to treat one patient who has MAI and is resistant to or can not tolerate standard of care. The drug is not otherwise available.

Eligibility Criteria

Inclusion

  • Treatment of one patient with MAI

Exclusion

  • No other patients will be treated

Key Trial Info

Start Date :

May 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2007

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT00652067

Start Date

May 1 2006

End Date

May 1 2007

Last Update

April 3 2008

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.